Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 21.1B | 16.5B | 14.1B | 12.8B |
Cost of revenue | 9.7B | 8.9B | 7.4B | 6.1B |
Gross profit | 11.4B | 7.7B | 6.7B | 6.7B |
Operating expense | ||||
Research & development | — | 68.6M | 31.7M | 37.2M |
Selling general and admin | — | 1.1B | 1.0B | 1.0B |
Other operating expenses | 5.2B | 2.2B | 2.2B | 2.1B |
Operating income | 4.0B | 2.4B | 2.0B | 2.1B |
Non operating interest income | ||||
Income | — | 20.6M | 18.5M | 4.9M |
Expense | 87.8M | 80.7M | 125.4M | 133.8M |
Other income expense | — | — | — | — |
Pretax income | 4.5B | 2.7B | 2.2B | 2.3B |
Tax provision | 1.1B | 669.6M | 538.1M | 638.8M |
Net income | 3.3B | 2.0B | 1.7B | 1.7B |
Basic EPS | 142.6 | 87.5 | 71.5 | 72.0 |
Diluted EPS | 142.6 | 87.5 | 71.5 | 72.0 |
Basic average shares | 23.2M | 23.2M | 23.2M | 23.2M |
Diluted average shares | 23.2M | 23.2M | 23.2M | 23.2M |
EBITDA | 5.0B | 3.0B | 2.5B | 2.5B |
Net income from continuing op. | 4.5B | 2.7B | 2.2B | 2.3B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |